Journal issues > Issue 4, June 2023 > Highlights from the 18^th biannual symposium Acute Leukaemias (ISALXVIII)

Highlights from the 18^th biannual symposium Acute Leukaemias (ISALXVIII)

SUMMARY

Leading topics at the international symposium Acute Leukaemias (ISALXVIII) in 2023 were: the new classifications for acute leukaemia, interpretation of clonal haematopoiesis (CHIP), advancing insights of venetoclax-azacitidine (VEN-AZA) administration and associated supportive care, the position of new treatment options in fit and unfit patients, the renewed role of maintenance, and first steps in bringing immunotherapy to the acute myeloid leukaemia (AML) population.

(BELG J HEMATOL 2023;14(4):186–91)

To read the full artice you have the following options:

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Hematology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €3.03

** (for healthcare professionals with prescribing authorisation working outside the field of Hematology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Hematology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)

Top

Highlights from the 18th biannual symposium Acute Leukaemias (ISALXVIII)

SUMMARY

To read the full artice you have the following options:

Highlights from the 18^th biannual symposium Acute Leukaemias (ISALXVIII)